Related Experiment Video

Updated: Oct 8, 2025

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

1.8K

Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control

Luca Piscitani1, Rita Del Pinto2, Andrea Basili3

  • 1Nephrology and Dialysis Unit, Department of Medicine, S. Salvatore Hospital, Via Vetoio, 67100, L'Aquila, Italy. lucpis90@virgilio.it.

High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|January 3, 2022
PubMed

Insights

Patients on hemodialysis show a weaker antibody response to the SARS-CoV-2 mRNA vaccine compared to healthy individuals. This reduced immune response in hemodialysis patients highlights potential challenges in achieving vaccine-induced immunity.

Area of Science:

  • Immunology
  • Nephrology
  • Vaccinology

Background:

  • Coronavirus disease 2019 (COVID-19) poses significant risks for patients undergoing chronic hemodialysis, associated with higher mortality and morbidity.
  • Understanding the immune response to vaccination in this vulnerable population is crucial for public health strategies.

Purpose of the Study:

  • To compare the immunogenicity of the BNT162b2 mRNA vaccine in patients receiving chronic hemodialysis versus individuals with normal kidney function.
  • To assess serum antibody titers against the SARS-CoV-2 spike antigen post-vaccination in both groups.

Main Methods:

  • A retrospective, observational case-control pilot study.
  • Participants included hemodialysis outpatients and a control group with preserved renal function, all fully vaccinated with BNT162b2 mRNA vaccine.
  • Exclusion criteria included prior COVID-19 infection.

Main Results:

  • Twenty-one hemodialysis patients and 16 controls were analyzed.
  • Hemodialysis patients exhibited significantly lower mean serum antibody titers to the SARS-CoV-2 spike antigen (492.39 IU/mL) compared to controls (1901.20 IU/mL, p < 0.001).
  • This difference persisted in an age-matched analysis.

Conclusions:

  • Hemodialysis patients demonstrate hyporesponsiveness to the BNT162b2 mRNA vaccine.
  • The findings suggest a diminished capacity for generating protective antibody levels in this patient group following vaccination.
Abstract

Keywords:
Antibody activityCOVID-19HemodialysismRNA vaccines

More Related Videos

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.3K
Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney08:26

Hydrodynamic Renal Pelvis Injection for Non-viral Expression of Proteins in the Kidney

Published on: January 8, 2018

18.9K

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
391
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
178
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
77.8K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
76
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
260
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
876